Dr. phil febbo
Web1 day ago · Dr. Phil Febbo, chief medical officer of Illumina, added: "We are honored to partner with Henry Ford Health to assess the potential benefits of integrating genomic testing within specialized care centers in the health care system. We share the belief that genomics should be integrated into standard of care across clinical indications as one of ... WebBy Dr. Phil Febbo, SVP, CMO 8 June 2024. 6 min read Illumina's COVID testing service By Dr. Phil Febbo, SVP, CMO 3 September 2024. 1 min read More expectant parents to get access to non-invasive prenatal testing By Dr. Phil Febbo, SVP, CMO 9 October 2024. Return to All Blog Articles. For Research Use Only.
Dr. phil febbo
Did you know?
WebDr. Phil G. Febbo is responsible for developing and executing the Company’s medical strategy to drive genomic testing into healthcare practice. Dr. Febbo has a successful track record of translational research, clinical excellence, and for embedding molecular insights into clinical care. Immediately before joining Illumina, Dr. Febbo served ... WebBy Dr. Phil Febbo, SVP, CMO 8 June 2024. 6 min read Illumina's COVID testing service By Dr. Phil Febbo, SVP, CMO 3 September 2024. 1 min read More expectant parents to …
WebDr. Phil Febbo was appointed as Illumina’s chief medical officer in March 2024 and is responsible for developing and executing the company’s medical strategy to drive genomic testing into ... WebMar 12, 2024 · SAN DIEGO--(BUSINESS WIRE)-- Illumina, Inc. (NASDAQ:ILMN) announced today the appointment of Dr. Phil Febbo, a leading physician scientist, as Chief Medical Officer (CMO), starting March 26, 2024.In his new role, Dr. Febbo will be responsible for developing and executing on the Company’s medical strategy to drive …
Web2 days ago · Dr. Phil Febbo, chief medical officer of Illumina, added: "We are honored to partner with Henry Ford Health to assess the potential benefits of integrating genomic testing within specialized care centers in the health care system. We share the belief that genomics should be integrated into standard of care across clinical indications as one of ... WebMar 1, 2024 · The estimated net worth of Phillip G. Febbo is at least $1.16 million as of April 6th, 2024. Dr. Febbo owns 5,774 shares of Illumina stock worth more than $1,161,209 as of January 14th. This net worth evaluation does not reflect any other investments that Dr. Febbo may own.
WebNew NextSeq 1000/2000 P1 and P2 600-Cycle Kits. New configurations will bring longer read capabilities with more output for immune repertoire, shotgun metagenomics and more
WebDr. Phil Febbo was appointed as Chief Medical Officer in March 2024. In this role, he is responsible for developing and executing the Company's medical strategy to accelerate … how to grow laundry businessWebNov 21, 2024 · Dr. Febbo has a successful track record of translational research, clinical excellence, and for embedding molecular insights into clinical care. Immediately before joining Illumina, Dr. Febbo served as CMO of Genomic Health. ... Phil Febbo, MD was appointed as Chief Medical Officer in March 2024. In this role, he is responsible for … john tyler famous quoteWebApr 21, 2024 · Dr. Febbo will serve on the ACMG Foundation Board from September 2024 to September 2024. Director Varian Medical Systems … john tyler grandchildren alive today